First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Complement Factor D Inhibitor BCX9930 in Healthy Participants.

pelecopan (BCX9930) - BioCryst

http://www.ncbi.nlm.nih.gov/pubmed/40292729

Amanda Mathis; Cynthia Parker; David Reynolds; Fugang Zhu; Matthew Davidson; Melanie Cornpropst; Stuart Mair; Sylvia Dobo; William P Sheridan; Xilin Chen; Yarlagadda S Babu

Apr 28, 2025